219 related articles for article (PubMed ID: 27135671)
21. Incomplete histological margins following planned narrow excision of canine appendicular soft tissue sarcomas and mast cell tumors, using the residual tumor classification scheme.
Haine DL; Pittaway R; Berlato D; Demetriou J
Vet Surg; 2022 Oct; 51(7):1078-1086. PubMed ID: 35830150
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma.
Villedieu EJ; Petite AF; Godolphin JD; Bacon NJ
J Am Vet Med Assoc; 2021 Jan; 258(2):179-185. PubMed ID: 33405989
[TBL] [Abstract][Full Text] [Related]
23. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
[TBL] [Abstract][Full Text] [Related]
24. Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases.
Chase D; Bray J; Ide A; Polton G
J Small Anim Pract; 2009 Nov; 50(11):568-74. PubMed ID: 19814769
[TBL] [Abstract][Full Text] [Related]
25. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
[TBL] [Abstract][Full Text] [Related]
26. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004).
Selting KA; Powers BE; Thompson LJ; Mittleman E; Tyler JW; Lafferty MH; Withrow SJ
J Am Vet Med Assoc; 2005 Nov; 227(9):1442-8. PubMed ID: 16279389
[TBL] [Abstract][Full Text] [Related]
27. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.
McKnight JA; Mauldin GN; McEntee MC; Meleo KA; Patnaik AK
J Am Vet Med Assoc; 2000 Jul; 217(2):205-10. PubMed ID: 10909459
[TBL] [Abstract][Full Text] [Related]
28. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002).
Phelps HA; Kuntz CA; Milner RJ; Powers BE; Bacon NJ
J Am Vet Med Assoc; 2011 Jul; 239(1):97-106. PubMed ID: 21718202
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of variables associated with outcomes in 41 dogs with incompletely excised high-grade soft tissue sarcomas treated with definitive-intent radiation therapy with or without chemotherapy.
Crownshaw AH; McEntee MC; Nolan MW; Gieger TL
J Am Vet Med Assoc; 2020 Apr; 256(7):783-791. PubMed ID: 32176583
[TBL] [Abstract][Full Text] [Related]
30. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.
Spugnini EP; Vincenzi B; Amadio B; Baldi A
Open Vet J; 2019 Apr; 9(1):88-93. PubMed ID: 31086772
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.
Dennis MM; McSporran KD; Bacon NJ; Schulman FY; Foster RA; Powers BE
Vet Pathol; 2011 Jan; 48(1):73-84. PubMed ID: 21139143
[TBL] [Abstract][Full Text] [Related]
33. A retrospective comparison of carbon dioxide surgical laser and non-laser excision for removal of cutaneous and subcutaneous soft-tissue sarcomas in dogs.
Agulian L; Mann FA; Middleton JR; Kim DY
N Z Vet J; 2020 Nov; 68(6):340-344. PubMed ID: 32529958
[No Abstract] [Full Text] [Related]
34. Postoperative radiotherapy for canine soft tissue sarcoma.
Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
37. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
38. Canine Cutaneous and Subcutaneous Soft Tissue Sarcoma: An Evidence-Based Review of Case Management.
Hohenhaus AE; Kelsey JL; Haddad J; Barber L; Palmisano M; Farrelly J; Soucy A
J Am Anim Hosp Assoc; 2016; 52(2):77-89. PubMed ID: 26808432
[TBL] [Abstract][Full Text] [Related]
39. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
Baker-Gabb M; Hunt GB; France MP
Aust Vet J; 2003 Dec; 81(12):732-8. PubMed ID: 15080482
[TBL] [Abstract][Full Text] [Related]
40. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]